Cutaneous aspergillosis in a lung transplant recipient
暂无分享,去创建一个
M. Lázaro | P. Ussetti | A. Ramos | R. Laporta | I. Sánchez-Romero | I. Sánchez‐Romero | Rosalía Laporta | Antonio Ramos | M. T. Lázaro
[1] Janet L. Hoffman,et al. Clinical Application of Voriconazole Concentrations in the Treatment of Invasive Aspergillosis , 2008, The Annals of pharmacotherapy.
[2] M. Haberal,et al. Multiple subcutaneous nodules leading to the diagnosis of pulmonary aspergillosis in a renal transplant recipient , 2007, Clinical transplantation.
[3] A. Cosimi,et al. Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] Joan Gavaldà,et al. Infección en el trasplante de pulmón , 2007, Enfermedades Infecciosas y Microbiología Clínica.
[5] J. Torre-Cisneros,et al. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. , 2007, Chest.
[6] J. Perfect,et al. Evaluation and management of Fungal infections in Immunocompromised patients , 2005, Dermatologic therapy.
[7] A. Milstone,et al. A survey of anti-fungal management in lung transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] H. Kim,et al. A case of primary cutaneous aspergillosis in a renal transplant recipient. , 2004, Transplantation proceedings.
[9] Nina Singh,et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] N. Smedira,et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[11] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[12] J. Perfect,et al. SAFETY OF AEROSOLIZED AMPHOTERICIN B LIPID COMPLEX IN LUNG TRANSPLANT RECIPIENTS12 , 2001, Transplantation.
[13] F. Martinez,et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. , 2001, Chest.
[14] William R. Kirkpatrick,et al. Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.
[15] Galimberti,et al. Cutaneous aspergillosis: a report of six cases , 1998, The British journal of dermatology.
[16] M. Wallace,et al. Cutaneous aspergillosis. , 1997, Cutis.
[17] P. Itin,et al. Outbreak of Invasive Mycoses Caused by Paecilomyces lilacinus from a Contaminated Skin Lotion , 1996, Annals of Internal Medicine.
[18] M. Stiller,et al. Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. , 1994, Journal of the American Academy of Dermatology.
[19] E. Bouza,et al. Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. , 1992, Diagnostic microbiology and infectious disease.
[20] H. Neu,et al. Primary cutaneous aspergillosis in six leukemic children. , 1985, Journal of the American Academy of Dermatology.